SUMMARY: Having missed a possible harm signal for the Oxford AstraZeneca COVID-19 vaccine, the delays in taking action continue
After the great interest shown by the UK Parliament, our readers, and the MHRA's enablers, we continue reviewing the minutes of the 26 April 2021 meeting of the MHRA’s Commission On Human Medicines (CHM) COVID-19 Vaccines Bene…